These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 21056895)
1. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions. Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895 [TBL] [Abstract][Full Text] [Related]
2. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512 [TBL] [Abstract][Full Text] [Related]
4. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
5. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Andea A; Sarkar F; Adsay VN Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]
8. Current understanding of precursors to pancreatic cancer. Takaori K J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195 [TBL] [Abstract][Full Text] [Related]
9. Where and when does pancreatic carcinoma start? Lüttges J; Hahn S; Klöppel G Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289 [TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach. Katabi N; Klimstra DS J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569 [TBL] [Abstract][Full Text] [Related]
11. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281 [TBL] [Abstract][Full Text] [Related]
12. Current topics on precursors to pancreatic cancer. Takaori K; Hruban RH; Maitra A; Tanigawa N Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic intraepithelial neoplasia revisited and updated. Sipos B; Frank S; Gress T; Hahn S; Klöppel G Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
15. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms. Chang X; Yu C; Li J; Yu S; Chen J Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816 [No Abstract] [Full Text] [Related]
16. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Adsay NV; Longnecker DS; Klimstra DS Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804 [TBL] [Abstract][Full Text] [Related]
17. [Pathologic characteristics and evaluation of the pancreatic cancer]. Fukushima N; Mukai K Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557 [TBL] [Abstract][Full Text] [Related]
18. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
19. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter. Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204 [TBL] [Abstract][Full Text] [Related]